This is what the articifial skin looks like.
The study was conducted on artificial human skin
By using artificial human skin, a research group from the University of Copenhagen have managed to block invasive growth in a skin cancer model.
The study has been published in Science Signaling and looks at what actually happens when a cell turns into a cancer cell.
“We have been studying one of the cells’ signalling pathways, the so-called TGF beta pathway. This pathway plays a critical role in the cell’s communication with its surroundings, and it controls e.g. cell growth and cell division. If these mechanisms are damaged, the cell may turn into a cancer cell and invade the surrounding tissue,” explains Professor and Team Lead Hans Wandall from the Department of Cellular and Molecular Medicine at the University of Copenhagen.
By using artificial human skin we are past the potentially problematic obstacle of whether results from tests on mice models can be transferred to human tissue.
Under normal circumstances, your skin cells will not just start to invade the hypodermis and wreak havoc. Instead, they will produce a new layer of skin. But when cancer cells emerge, the cells no longer respect the boundaries between skin layers, and they start to invade each other. This is called invasive growth.
Hans Wandall and his colleagues have been studying the TGF beta pathway and applied methods for blocking invasive growth and thus curbing the invasive growth in skin cancer.
“We already have various drugs that can block these signalling pathways and which may be used in tests. We have used some of them in this study,” explains Associate Professor and co-author of the study Sally Dabelsteen from the School of Dentistry.
Hans Wandall and Sally Dabelsteen have worked together with Dr. Zilu Ye and Professor Jesper V. Olsen from the Novo Nordisk Foundation Center for Protein Research at the Faculty of Health and Medical Sciences.
“Some of these drugs have already been tested on humans, and some are in the process of being tested in connection with other types of cancer. They could also be tested on skin cancer specifically,” she says.
Artificial skin is the closest we get to real human skin
The artificial skin used by the researchers in the new study consists of artificial, genetically manipulated human skin cells. Skin cells are produced on subcutaneous tissue made of collagen. This makes the cells grow in layers, just like real human skin.
Unlike mice models, the skin model, which is another word for artificial skin, allows researchers to introduce artificial genetic changes relatively quickly, which provide insight into the systems that support skin development and renewal.
This way they are also able to reproduce and follow the development of other skin disorders, not just skin cancer.
“By using artificial human skin we are past the potentially problematic obstacle of whether results from tests on mice models can be transferred to human tissue. Previously, we used mice models in most studies of this kind. Instead, we can now conclude that these substances probably are not harmful and could work in practice, because the artificial skin means that we are closer to human reality,” says Hans Wandall.
The artificial skin used by the researchers resembles the skin used to test cosmetics in the EU, which banned animal testing in 2004. However, artificial skin does not allow the researchers to test the effect of a drug on the entire organism, Hans Wandall points out. Skin models like the one used here have been used by cosmetics companies since the mid-1980s.
“We can study the effect focussing on the individual organ – the skin – and then we reap experiences with regard to how molecules work, while we seek to determine whether they damage the structure of the skin and the healthy skin cells,” he says.
Original Article: Artificial human skin paves the way to new skin cancer therapy
More from: University of Copenhagen
The Latest Updates from Bing News
Go deeper with Bing News on:
Artificial human skin
- Gym Teacher Collapses After Artificial Hip 'Catastrophically' Failed, Prompting Legal Action Against Recalled Implant
According to a report by CBS News, a metal part from the artificial implant in his right hip had suddenly ... from juicy celebrity news to compelling human interest stories. Related: Adam Sandler Says ...
- From resistance to resilience: Reprogramming drug resistance signals with an artificial gene circuit device
In all the treatment experiments tested, including vincristine-resistant cell lines, human-derived tumor organoids, and mouse models, the artificial NF-κB/OIP5 gene circuit device proved to ...
- AI is more likely to become as clever as a dog in the next few years than mimic a human, industry godfather says
Meta's chief AI scientist Yann LeCun is sceptical that AI will reach human-level intelligence anytime soon ... by the chipmaker Nvidia's CEO Jensen Huang who recently said that artificial general ...
- Human Biology News
2023 — Scientists have created tiny moving biological robots from human tracheal cells that can encourage the growth of neurons across artificial 'wounds' in the lab. Using patients' own cells ...
- Color-based robotic sensor can detect multiple stimuli just like skin
When it comes to robotics, the search to create an artificial skin that behaves like the real thing ... Owing to the remarkable properties of the somatosensory system, human skin compactly perceives ...
Go deeper with Bing News on:
- Medical student helps discover her own cancer in ultrasound class
Sally Rohan's decision to go to medical school may have helped save her life. Rohan, 27, is currently undergoing treatment for papillary thyroid cancer, a type of cancer that she said was first ...
- Massachusetts Biotech Plummets as Skin Cancer Trial Fails
Disappointing Trial but Positive Data in Other Study This disappointing clinical trial update comes alongside more positive data from a separate study testing RP1 in anti-PD1 failed non-melanoma skin ...
- Portuguese League against Cancer collects over 1.6 million euros
The Portuguese League Against Cancer (LPCC) raised more than 1.6 million euros in this year's fundraising, an amount that surpassed last year's and which was collected by more than 20,000 volunteers.
- Groundbreaking Skin Cancer service being blocked by up to two thirds of dermatology departments
Dublin hospitals, including St. James’s Hospital, Beaumont Hospital, Connolly Hospital Blanchardstown, and Our Lady of Lourdes Hospital Drogheda, have successfully employed AllView’s Teledermatology ...
- Groundbreaking skin cancer service blocked by two thirds of dermatology departments
A groundbreaking skin cancer service is being blocked by over two thirds of dermatology departments. Despite the HSE approving, funding and capacity for 20,000 HSE patients in 2023, the majority of ...